应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ENGN ENGENE HOLDINGS INC
休市中 02-06 16:00:00 EST
9.55
+0.69
+7.79%
盘后
9.55
+0.00
0.00%
19:23 EST
最高
9.78
最低
8.95
成交量
41.71万
今开
8.95
昨收
8.86
日振幅
9.31%
总市值
6.40亿
流通市值
3.57亿
总股本
6,698万
成交额
387.43万
换手率
1.12%
流通股本
3,733万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
ENGENE HOLDINGS INC 获得高达1亿美元资金,用于膀胱癌疗法Detalimogene的研发与商业化
美股速递 · 01-21
ENGENE HOLDINGS INC 获得高达1亿美元资金,用于膀胱癌疗法Detalimogene的研发与商业化
Engene Holdings Inc.盘中异动 临近午盘股价大跌5.04%
市场透视 · 01-07
Engene Holdings Inc.盘中异动 临近午盘股价大跌5.04%
ENGENE HOLDINGS INC - 现金及可交易证券加上11月融资所得预计将为2028年下半年提供现金流支持
美股速递 · 2025-12-23
ENGENE HOLDINGS INC - 现金及可交易证券加上11月融资所得预计将为2028年下半年提供现金流支持
ENGENE HOLDINGS INC - FDA 选择 Detalimogene Voraplasmid 参与化学、制造及控制开发与准备试点项目
美股速递 · 2025-12-02
ENGENE HOLDINGS INC - FDA 选择 Detalimogene Voraplasmid 参与化学、制造及控制开发与准备试点项目
enGene的Detalimogene入选FDA制造试点项目以支持制造准备
美股速递 · 2025-12-02
enGene的Detalimogene入选FDA制造试点项目以支持制造准备
Engene Holdings Inc.盘中异动 早盘快速上涨5.75%
市场透视 · 2025-11-25
Engene Holdings Inc.盘中异动 早盘快速上涨5.75%
enGene Holdings 提交普通股发行申请,规模未披露 - SEC 文件
投资观察 · 2025-11-20
enGene Holdings 提交普通股发行申请,规模未披露 - SEC 文件
ENGENE HOLDINGS INC - 定价为每股8.50美元的12,558,823股普通股
美股速递 · 2025-11-13
ENGENE HOLDINGS INC - 定价为每股8.50美元的12,558,823股普通股
enGene宣布拟进行普通股公开发行
投资观察 · 2025-11-13
enGene宣布拟进行普通股公开发行
Engene Holdings Inc.盘中异动 早盘大幅拉升6.88%
市场透视 · 2025-10-27
Engene Holdings Inc.盘中异动 早盘大幅拉升6.88%
Engene Holdings Inc.盘中异动 股价大跌6.64%
市场透视 · 2025-10-10
Engene Holdings Inc.盘中异动 股价大跌6.64%
enGene Holdings Inc根据纳斯达克上市规则报告诱导性股权激励
投资观察 · 2025-10-02
enGene Holdings Inc根据纳斯达克上市规则报告诱导性股权激励
ENGENE HOLDINGS INC:现金及有价证券达2.249亿美元,预计可维持运营至2027年
美股速递 · 2025-09-12
ENGENE HOLDINGS INC:现金及有价证券达2.249亿美元,预计可维持运营至2027年
enGene Holdings(ENGN.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.48美元,前值为-0.46美元,预期值为-0.38美元。
金融界 · 2025-03-11
enGene Holdings(ENGN.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.48美元,前值为-0.46美元,预期值为-0.38美元。
enGene Holdings 2025年第一季度GAAP每股亏损$(0.48),低于预期$(0.39)
财报速递 · 2025-03-11
enGene Holdings 2025年第一季度GAAP每股亏损$(0.48),低于预期$(0.39)
Engene Holdings Inc.盘中异动 早盘股价大涨6.10%
市场透视 · 2025-03-10
Engene Holdings Inc.盘中异动 早盘股价大涨6.10%
Engene Holdings Inc.盘中异动 股价大跌5.60%
市场透视 · 2025-03-06
Engene Holdings Inc.盘中异动 股价大跌5.60%
Engene Holdings Inc.盘中异动 大幅上涨7.58%
市场透视 · 2025-02-27
Engene Holdings Inc.盘中异动 大幅上涨7.58%
Engene Holdings Inc.盘中异动 股价大涨5.34%
市场透视 · 2025-02-26
Engene Holdings Inc.盘中异动 股价大涨5.34%
Engene Holdings Inc.盘中异动 早盘快速下跌5.09%
市场透视 · 2025-02-25
Engene Holdings Inc.盘中异动 早盘快速下跌5.09%
加载更多
公司概况
公司名称:
ENGENE HOLDINGS INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
enGene Holdings Inc.于2023年4月24日根据加拿大联邦法律注册为14963148 Canada Inc.,并于2023年5月9日更名为enGene Holdings Inc.。该公司是一家临床阶段的生物技术公司,通过向黏膜组织和其他器官提供治疗药物,将基因医学纳入主流,目标是创造新的方法来解决临床需求高的疾病,从非肌肉浸润性膀胱癌(NMIBC)开始。该公司正在开发基于其新型和专有的双重衍生的壳聚糖或“DDX”基因递送平台的非病毒基因疗法,该平台允许将多种基因货物直接本地化递送至黏膜组织和其他器官。
发行价格:
--
{"stockData":{"symbol":"ENGN","market":"US","secType":"STK","nameCN":"ENGENE HOLDINGS INC","latestPrice":9.55,"timestamp":1770411600000,"preClose":8.86,"halted":0,"volume":417110,"hourTrading":{"tag":"盘后","latestPrice":9.55,"preClose":9.55,"latestTime":"19:23 EST","volume":1000,"amount":9562.87,"timestamp":1770423820716,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.07787810383747193,"floatShares":37332800,"shares":66984661,"eps":-2.294663,"marketStatus":"休市中","change":0.69,"latestTime":"02-06 16:00:00 EST","open":8.95,"high":9.775,"low":8.95,"amount":3874251.5723099997,"amplitude":0.093115,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.294663,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":8.86,"postHourTrading":{"tag":"盘后","latestPrice":9.55,"preClose":9.55,"latestTime":"19:23 EST","volume":1000,"amount":9562.87,"timestamp":1770423820716,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8895416637688531},"requestUrl":"/m/hq/s/ENGN","defaultTab":"news","newsList":[{"id":"1112241251","title":"ENGENE HOLDINGS INC 获得高达1亿美元资金,用于膀胱癌疗法Detalimogene的研发与商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1112241251","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112241251?lang=zh_cn&edition=full","pubTime":"2026-01-21 06:42","pubTimestamp":1768948933,"startTime":"0","endTime":"0","summary":"ENGENE HOLDINGS INC 已成功获得一笔总额高达1亿美元的融资,这笔资金将专项用于其膀胱癌治疗药物Detalimogene的后续开发及商业化进程。此次融资为Detalimogene项目的推进提供了强有力的资金保障,有望加速该创新疗法的研发与市场应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2601716098","title":"Engene Holdings Inc.盘中异动 临近午盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601716098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601716098?lang=zh_cn&edition=full","pubTime":"2026-01-07 00:38","pubTimestamp":1767717500,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日00时38分,Engene Holdings Inc.股票出现波动,股价大幅下挫5.04%。Engene Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.14%。Engene Holdings Inc.公司简介:enGene Holdings Inc是一家临床阶段的生物技术公司,致力于通过将治疗药物递送至黏膜组织和其他器官,推动基因医学的主流化应用,旨在为解决临床需求高的疾病创造新的途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107003821a4a4260a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107003821a4a4260a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DDX","ENGN","BK4139"],"gpt_icon":0},{"id":"1108419306","title":"ENGENE HOLDINGS INC - 现金及可交易证券加上11月融资所得预计将为2028年下半年提供现金流支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1108419306","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108419306?lang=zh_cn&edition=full","pubTime":"2025-12-23 05:16","pubTimestamp":1766438213,"startTime":"0","endTime":"0","summary":"ENGENE HOLDINGS INC - 现金及可交易证券加上11月融资所得预计将为2028年下半年提供现金流支持","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"1145646678","title":"ENGENE HOLDINGS INC - FDA 选择 Detalimogene Voraplasmid 参与化学、制造及控制开发与准备试点项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1145646678","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145646678?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:35","pubTimestamp":1764678929,"startTime":"0","endTime":"0","summary":"ENGENE HOLDINGS INC - FDA 选择 Detalimogene Voraplasmid 参与化学、制造及控制开发与准备试点项目","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"1176799218","title":"enGene的Detalimogene入选FDA制造试点项目以支持制造准备","url":"https://stock-news.laohu8.com/highlight/detail?id=1176799218","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176799218?lang=zh_cn&edition=full","pubTime":"2025-12-02 20:31","pubTimestamp":1764678692,"startTime":"0","endTime":"0","summary":"enGene的Detalimogene入选FDA制造试点项目,以支持其制造准备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2586492894","title":"Engene Holdings Inc.盘中异动 早盘快速上涨5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586492894","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586492894?lang=zh_cn&edition=full","pubTime":"2025-11-25 00:21","pubTimestamp":1764001295,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日00时21分,Engene Holdings Inc.股票出现波动,股价急速上涨5.75%。Engene Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.71%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Enlivex Therapeutics Ltd.、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大,Enlivex Therapeutics Ltd.、Pasithea Therapeutics Corp.、Osr Holdings, Inc.较为活跃,换手率分别为730.48%、499.41%、90.53%,振幅较大的相关个股有Enlivex Therapeutics Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 ,振幅分别为56.87%、45.45%、42.12%。Engene Holdings Inc.公司简介:enGene Holdings Inc .是一家临床阶段的生物技术公司,致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125002135a4b77cdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125002135a4b77cdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENGN","DDX","BK4139"],"gpt_icon":0},{"id":"1197556328","title":"enGene Holdings 提交普通股发行申请,规模未披露 - SEC 文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1197556328","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197556328?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:31","pubTimestamp":1763573466,"startTime":"0","endTime":"0","summary":"11月12日——enGene Holdings Inc :*ENGENE HOLDINGS 提交普通股发行申请,规模未披露 - SEC 文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"1103094117","title":"ENGENE HOLDINGS INC - 定价为每股8.50美元的12,558,823股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1103094117","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103094117?lang=zh_cn&edition=full","pubTime":"2025-11-13 13:28","pubTimestamp":1763011692,"startTime":"0","endTime":"0","summary":"ENGENE HOLDINGS INC - 定价为每股8.50美元的12,558,823股普通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"1189870178","title":"enGene宣布拟进行普通股公开发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1189870178","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189870178?lang=zh_cn&edition=full","pubTime":"2025-11-13 05:14","pubTimestamp":1762982070,"startTime":"0","endTime":"0","summary":"11月12日 - enGene Holdings Inc宣布拟进行普通股公开发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2578671721","title":"Engene Holdings Inc.盘中异动 早盘大幅拉升6.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578671721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578671721?lang=zh_cn&edition=full","pubTime":"2025-10-27 21:39","pubTimestamp":1761572351,"startTime":"0","endTime":"0","summary":"北京时间2025年10月27日21时39分,Engene Holdings Inc.股票出现波动,股价急速拉升6.88%。Engene Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.86%。其相关个股中,戴纳基、Avidity Biosciences, Inc.、Ethzilla Corporation C/Wts 06/11/2025涨幅较大,Nls Pharmaceutics Ltd.、Cellectar Biosciences, Inc.、Aditxt, Inc.较为活跃,换手率分别为140.02%、114.31%、94.88%,振幅较大的相关个股有冠科美博、Zenas Biopharma, Inc.、Fate Therapeutics, Inc.,振幅分别为19.22%、16.11%、13.33%。Engene Holdings Inc.公司简介:enGene Holdings Inc .是一家临床阶段的生物技术公司,致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027213911a477c970&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027213911a477c970&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2574821654","title":"Engene Holdings Inc.盘中异动 股价大跌6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574821654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574821654?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:24","pubTimestamp":1760106281,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日22时24分,Engene Holdings Inc.股票出现异动,股价大幅下挫6.64%。Engene Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,Io Biotech, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Gyre Therapeutics, Inc.涨幅较大,Aditxt, Inc.、Cdt Equity Inc.、Intensity Therapeutics, Inc.较为活跃,换手率分别为310.02%、64.48%、47.85%,振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Briacell Therapeutics Corp C/Wts 26/02/2026、知临集团,振幅分别为39.68%、33.20%、29.54%。Engene Holdings Inc.公司简介:enGene Holdings Inc .是一家临床阶段的生物技术公司,致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022244194c20110&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022244194c20110&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"1163035261","title":"enGene Holdings Inc根据纳斯达克上市规则报告诱导性股权激励","url":"https://stock-news.laohu8.com/highlight/detail?id=1163035261","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163035261?lang=zh_cn&edition=full","pubTime":"2025-10-02 04:22","pubTimestamp":1759350152,"startTime":"0","endTime":"0","summary":"enGene Holdings Inc宣布,公司已根据纳斯达克上市规则5635(C)(4)条款报告诱导性股权激励计划。\n该规则条款通常涉及向新员工或现有员工提供股权激励作为雇佣诱导的相关披露要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"1123324809","title":"ENGENE HOLDINGS INC:现金及有价证券达2.249亿美元,预计可维持运营至2027年","url":"https://stock-news.laohu8.com/highlight/detail?id=1123324809","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123324809?lang=zh_cn&edition=full","pubTime":"2025-09-12 04:15","pubTimestamp":1757621713,"startTime":"0","endTime":"0","summary":"ENGENE HOLDINGS INC:现金及有价证券达2.249亿美元,预计可维持运营至2027年","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2518789484","title":"enGene Holdings(ENGN.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.48美元,前值为-0.46美元,预期值为-0.38美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518789484","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518789484?lang=zh_cn&edition=full","pubTime":"2025-03-11 05:45","pubTimestamp":1741643101,"startTime":"0","endTime":"0","summary":"enGene Holdings(ENGN.US):2025年Q1财报实现营收0美元,前值为0美元;每股收益为-0.48美元,前值为-0.46美元,预期值为-0.38美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11054548643207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ENGN"],"gpt_icon":0},{"id":"1192034044","title":"enGene Holdings 2025年第一季度GAAP每股亏损$(0.48),低于预期$(0.39)","url":"https://stock-news.laohu8.com/highlight/detail?id=1192034044","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192034044?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:14","pubTimestamp":1741637680,"startTime":"0","endTime":"0","summary":"enGene Holdings 公布季度每股亏损$,低于分析师共识预期$,下降23.08%。相比去年同期的每股亏损$,这是下降了4.35%。以上内容来自Benzinga Earnings专栏,原文如下:enGene Holdings reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 23.08 percent. This is a 4.35 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"enGene Holdings 2025年第一季度GAAP每股亏损$(0.48),低于预期$(0.39)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN"],"gpt_icon":0},{"id":"2518222407","title":"Engene Holdings Inc.盘中异动 早盘股价大涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222407?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:36","pubTimestamp":1741613793,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时36分,Engene Holdings Inc.股票出现波动,股价大幅上涨6.10%。Engene Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.42%。其相关个股中,Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大,Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为447.98%、67.42%、50.45%,振幅较大的相关个股有Akero Therapeutics, Inc.、Seer, Inc.、珐博进,振幅分别为100.05%、98.72%、98.49%。Engene Holdings Inc.公司简介:enGene Holdings Inc .是一家临床阶段的生物技术公司,致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021363398a29e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021363398a29e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENGN","BK4139"],"gpt_icon":0},{"id":"2517294715","title":"Engene Holdings Inc.盘中异动 股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517294715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517294715?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:30","pubTimestamp":1741195858,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时30分,Engene Holdings Inc.股票出现异动,股价大幅下跌5.60%。Engene Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.24%。其相关个股中,Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Celularity Inc.涨幅较大,Silexion Therapeutics Corp、Tc Biopharm Plc、Bioxcel Therapeutics, Inc.较为活跃,换手率分别为935.88%、304.12%、292.38%,振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.,振幅分别为82.59%、54.27%、47.22%。Engene Holdings Inc.公司简介:enGene Holdings Inc .是一家临床阶段的生物技术公司,致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306013058989d6e13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306013058989d6e13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2514386190","title":"Engene Holdings Inc.盘中异动 大幅上涨7.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386190?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:44","pubTimestamp":1740667477,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时44分,Engene Holdings Inc.股票出现波动,股价急速上涨7.58%。Engene Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.75%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Tiziana Life Sciences Ltd、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为456.35%、95.15%、83.14%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tiziana Life Sciences Ltd,振幅分别为59.85%、21.99%、17.35%。Engene Holdings Inc.公司简介:enGene Holdings Inc .是一家临床阶段的生物技术公司,致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272244379632b3b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272244379632b3b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2514856616","title":"Engene Holdings Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856616?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580471,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分,Engene Holdings Inc.股票出现异动,股价快速拉升5.34%。截至发稿,该股报5.92美元/股,成交量1341股,换手率0.00%,振幅2.67%。Engene Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.21%。Engene Holdings Inc.公司简介:enGene Holdings Inc .是一家临床阶段的生物技术公司,致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223431abddedbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223431abddedbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENGN"],"gpt_icon":0},{"id":"2514775486","title":"Engene Holdings Inc.盘中异动 早盘快速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514775486?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:08","pubTimestamp":1740413296,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时08分,Engene Holdings Inc.股票出现波动,股价急速跳水5.09%。Engene Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.07%。其相关个股中,Pepgen Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为240.54%、104.55%、32.30%,振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为162.04%、55.69%、53.34%。Engene Holdings Inc.公司简介:enGene Holdings Inc .是一家临床阶段的生物技术公司,致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225000817962eaf0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225000817962eaf0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENGN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.engene.com","stockEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.1235},{"period":"3month","weight":0.5759},{"period":"6month","weight":1.5951},{"period":"1year","weight":0.5039},{"period":"ytd","weight":0.0576}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"enGene Holdings Inc.于2023年4月24日根据加拿大联邦法律注册为14963148 Canada Inc.,并于2023年5月9日更名为enGene Holdings Inc.。该公司是一家临床阶段的生物技术公司,通过向黏膜组织和其他器官提供治疗药物,将基因医学纳入主流,目标是创造新的方法来解决临床需求高的疾病,从非肌肉浸润性膀胱癌(NMIBC)开始。该公司正在开发基于其新型和专有的双重衍生的壳聚糖或“DDX”基因递送平台的非病毒基因疗法,该平台允许将多种基因货物直接本地化递送至黏膜组织和其他器官。","exchange":"NASDAQ","name":"ENGENE HOLDINGS INC","nameEN":"ENGENE HOLDINGS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ENGENE HOLDINGS INC(ENGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ENGENE HOLDINGS INC(ENGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ENGENE HOLDINGS INC,ENGN,ENGENE HOLDINGS INC股票,ENGENE HOLDINGS INC股票老虎,ENGENE HOLDINGS INC股票老虎国际,ENGENE HOLDINGS INC行情,ENGENE HOLDINGS INC股票行情,ENGENE HOLDINGS INC股价,ENGENE HOLDINGS INC股市,ENGENE HOLDINGS INC股票价格,ENGENE HOLDINGS INC股票交易,ENGENE HOLDINGS INC股票购买,ENGENE HOLDINGS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ENGENE HOLDINGS INC(ENGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ENGENE HOLDINGS INC(ENGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}